Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System
December 10, 2019 02:00 ET
|
Zealand Pharma
Company announcement – No. 44 / 2019 Zealand Pharma partner Beta Bionics receives FDA Breakthrough Device Designation for the iLet™ Bionic Pancreas System The iLet is a pocket-sized, wearable...
Zealand Pharma completes equity investment in strategic partner Beta Bionics
January 04, 2019 04:06 ET
|
Zealand Pharma
Press release – No. 1 / 2019 Zealand Pharma completes equity investment in strategic partner Beta Bionics Zealand Pharma invests USD 3.5 million in the final close of strategic partner Beta...